JCM | Free Full-Text | Antiarrhythmic Effect of Sacubitril-Valsartan: Cause or Consequence of Clinical Improvement?
Practical guidance on the use of sacubitril/valsartan for heart failure | SpringerLink
Clinical outcomes of Sacubitril/Valsartan in patients with acute heart failure: A multi-institution study - eClinicalMedicine
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF | JACC: Heart Failure
Kidney Research and Clinical Practice
Frontiers | Assessment of Ultra-Early Administration of Sacubitril Valsartan to Improve Cardiac Remodeling in Patients With Acute Myocardial Infarction Following Primary PCI: Rational and Design of a Prospective, Multicenter, Randomized Controlled Trial
Insights into implementation of sacubitril/valsartan into clinical practice - Martens - 2018 - ESC Heart Failure - Wiley Online Library
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction | Heart
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial - ScienceDirect
JCM | Free Full-Text | Looking for a Tailored Therapy for Heart Failure: Are We Capable of Treating the Patient Instead of the Disease?
Forest plot of indirect comparisons used to estimate the effects of... | Download Scientific Diagram
Perks and Pitfalls of Performance-Linked Reimbursement for Novel Drugs: The Case of Sacubitril-Valsartan | Circulation: Cardiovascular Quality and Outcomes
Frontiers | Sacubitril-Valsartan Compared With Enalapril for the Treatment of Heart Failure: A Decision-Analytic Markov Model Simulation in China
Frontiers | Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF - ScienceDirect
Forest plot of indirect comparisons used to estimate the effects of... | Download Scientific Diagram
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction | Heart
Estimating the Lifetime Benefits of Treatments for Heart Failure - ScienceDirect
A randomized clinical trial on the short‐term effects of 12‐week sacubitril/ valsartan vs. enalapril on peak oxygen consumption in patients with heart failure with reduced ejection fraction: results from the ACTIVITY‐HF study -
Clinical outcomes of Sacubitril/Valsartan in patients with acute heart failure: A multi-institution study - eClinicalMedicine
Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction | JACC: Heart Failure
The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review - Rui Zhang, Xiaotong Sun, Ya Li, Wenzheng He, Hongguang Zhu, Baoshan Liu, Aiyuan Zhang, 2022
Sacubitril/Valsartan For Heart Failure & Ejection Fraction
Sacubitril/Valsartan For Heart Failure & Ejection Fraction
PDF) Estimating the Long-Term Treatment Benefits of Sacubitril-Valsartan
Sacubitril/Valsartan For Heart Failure & Ejection Fraction
Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial | JACC: Heart Failure
